Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 µg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler
- 25 March 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Drug Investigation
- Vol. 35 (5), 319-326
- https://doi.org/10.1007/s40261-015-0282-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Pharmacokinetics and Pharmacodynamics of Fluticasone Propionate and Salmeterol Delivered as a Combination Dry Powder from a Capsule-Based Inhaler and a Multidose Inhaler in Asthma and COPD PatientsJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2014
- Lung Physiology and Aerosol Deposition Imaged with Positron Emission TomographyJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2013
- Asthma That Is Not Well-Controlled Is Associated with Increased Healthcare Utilization and Decreased Quality of LifeJournal of Asthma, 2010
- Salmeterol/Fluticasone PropionateDrugs, 2009
- The burden of asthma in children: an Asian perspectivePaediatric Respiratory Reviews, 2005
- The burden of asthma in children: a Latin American perspectivePaediatric Respiratory Reviews, 2005
- The global burden of asthma: executive summary of the GINA Dissemination Committee ReportAllergy, 2004
- Asthma control in the Asia-Pacific region: The asthma insights and reality in Asia-Pacific studyJournal of Allergy and Clinical Immunology, 2003
- Clinical Pharmacokinetics of SalmeterolClinical Pharmacokinetics, 2002
- Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.American Journal of Respiratory and Critical Care Medicine, 1996